Gene fragments are pieces of genes containing only the exons (those parts of the gene which actually encode the protein sequence). They are composed of cDNA. Gene Fragment can be used in CRISPR-Based Genome Editing, Recombinant Antibody Engineering, cloning process, qPCR and PCR Controls, Enzyme Engineering, Vaccine Research, High Resolution Melt (HRM) Assays etc field.
The global market for Gene Fragment was estimated to be worth US$ 263.8 million in 2023 and is forecast to a readjusted size of US$ 566.5 million by 2030 with a CAGR of 11.4% during the forecast period 2024-2030
Global key players of gene fragment include Integrated DNA Technologies, Thermo Scientific, Eurofins Scientific, GenScript Biotech, Azenta Life Sciences, etc. The top five players hold a share over 70%. North America is the largest market, has a share about 40%, followed by Asia-Pacific, and Europe, with share 29% and 25%, separately.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Gene Fragment, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Gene Fragment by region & country, by Type, and by Application.
The Gene Fragment market size, estimations, and forecasts are provided in terms of sales volume (Million bp) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gene Fragment.
麻豆原创 Segmentation
By Company
Integrated DNA Technologies
Thermo Scientific
Eurofins Scientific
GenScript Biotech
Azenta Life Sciences
Twist Bioscience
Synbio Technologies
Bio Basic
BiOligo Biotechnology
Segment by Type:
0-999 bp
1000-1999 bp
2000-3999 bp
4000+ bp
Segment by Application
CRISPR-based Genome Editing
Antibody Engineering
Cloning Process
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Gene Fragment manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Gene Fragment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Gene Fragment in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 麻豆原创 Overview
1.1 Gene Fragment Product Introduction
1.2 Global Gene Fragment 麻豆原创 Size Forecast
1.2.1 Global Gene Fragment Sales Value (2019-2030)
1.2.2 Global Gene Fragment Sales Volume (2019-2030)
1.2.3 Global Gene Fragment Sales Price (2019-2030)
1.3 Gene Fragment 麻豆原创 Trends & Drivers
1.3.1 Gene Fragment Industry Trends
1.3.2 Gene Fragment 麻豆原创 Drivers & Opportunity
1.3.3 Gene Fragment 麻豆原创 Challenges
1.3.4 Gene Fragment 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Gene Fragment Players Revenue Ranking (2023)
2.2 Global Gene Fragment Revenue by Company (2019-2024)
2.3 Global Gene Fragment Players Sales Volume Ranking (2023)
2.4 Global Gene Fragment Sales Volume by Company Players (2019-2024)
2.5 Global Gene Fragment Average Price by Company (2019-2024)
2.6 Key Manufacturers Gene Fragment Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Gene Fragment Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Gene Fragment
2.9 Gene Fragment 麻豆原创 Competitive Analysis
2.9.1 Gene Fragment 麻豆原创 Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Gene Fragment Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Fragment as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 0-999 bp
3.1.2 1000-1999 bp
3.1.3 2000-3999 bp
3.1.4 4000+ bp
3.2 Global Gene Fragment Sales Value by Type
3.2.1 Global Gene Fragment Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Gene Fragment Sales Value, by Type (2019-2030)
3.2.3 Global Gene Fragment Sales Value, by Type (%) (2019-2030)
3.3 Global Gene Fragment Sales Volume by Type
3.3.1 Global Gene Fragment Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Gene Fragment Sales Volume, by Type (2019-2030)
3.3.3 Global Gene Fragment Sales Volume, by Type (%) (2019-2030)
3.4 Global Gene Fragment Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 CRISPR-based Genome Editing
4.1.2 Antibody Engineering
4.1.3 Cloning Process
4.1.4 Others
4.2 Global Gene Fragment Sales Value by Application
4.2.1 Global Gene Fragment Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Gene Fragment Sales Value, by Application (2019-2030)
4.2.3 Global Gene Fragment Sales Value, by Application (%) (2019-2030)
4.3 Global Gene Fragment Sales Volume by Application
4.3.1 Global Gene Fragment Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Gene Fragment Sales Volume, by Application (2019-2030)
4.3.3 Global Gene Fragment Sales Volume, by Application (%) (2019-2030)
4.4 Global Gene Fragment Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Gene Fragment Sales Value by Region
5.1.1 Global Gene Fragment Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Gene Fragment Sales Value by Region (2019-2024)
5.1.3 Global Gene Fragment Sales Value by Region (2025-2030)
5.1.4 Global Gene Fragment Sales Value by Region (%), (2019-2030)
5.2 Global Gene Fragment Sales Volume by Region
5.2.1 Global Gene Fragment Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Gene Fragment Sales Volume by Region (2019-2024)
5.2.3 Global Gene Fragment Sales Volume by Region (2025-2030)
5.2.4 Global Gene Fragment Sales Volume by Region (%), (2019-2030)
5.3 Global Gene Fragment Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Gene Fragment Sales Value, 2019-2030
5.4.2 North America Gene Fragment Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Gene Fragment Sales Value, 2019-2030
5.5.2 Europe Gene Fragment Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Gene Fragment Sales Value, 2019-2030
5.6.2 Asia Pacific Gene Fragment Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Gene Fragment Sales Value, 2019-2030
5.7.2 South America Gene Fragment Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Gene Fragment Sales Value, 2019-2030
5.8.2 Middle East & Africa Gene Fragment Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Gene Fragment Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Gene Fragment Sales Value
6.2.1 Key Countries/Regions Gene Fragment Sales Value, 2019-2030
6.2.2 Key Countries/Regions Gene Fragment Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Gene Fragment Sales Value, 2019-2030
6.3.2 United States Gene Fragment Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Gene Fragment Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Gene Fragment Sales Value, 2019-2030
6.4.2 Europe Gene Fragment Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Gene Fragment Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Gene Fragment Sales Value, 2019-2030
6.5.2 China Gene Fragment Sales Value by Type (%), 2023 VS 2030
6.5.3 China Gene Fragment Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Gene Fragment Sales Value, 2019-2030
6.6.2 Japan Gene Fragment Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Gene Fragment Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Gene Fragment Sales Value, 2019-2030
6.7.2 South Korea Gene Fragment Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Gene Fragment Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Gene Fragment Sales Value, 2019-2030
6.8.2 Southeast Asia Gene Fragment Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Gene Fragment Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Gene Fragment Sales Value, 2019-2030
6.9.2 India Gene Fragment Sales Value by Type (%), 2023 VS 2030
6.9.3 India Gene Fragment Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Integrated DNA Technologies
7.1.1 Integrated DNA Technologies Company Information
7.1.2 Integrated DNA Technologies Introduction and Business Overview
7.1.3 Integrated DNA Technologies Gene Fragment Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Integrated DNA Technologies Gene Fragment Product Offerings
7.1.5 Integrated DNA Technologies Recent Development
7.2 Thermo Scientific
7.2.1 Thermo Scientific Company Information
7.2.2 Thermo Scientific Introduction and Business Overview
7.2.3 Thermo Scientific Gene Fragment Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Thermo Scientific Gene Fragment Product Offerings
7.2.5 Thermo Scientific Recent Development
7.3 Eurofins Scientific
7.3.1 Eurofins Scientific Company Information
7.3.2 Eurofins Scientific Introduction and Business Overview
7.3.3 Eurofins Scientific Gene Fragment Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Eurofins Scientific Gene Fragment Product Offerings
7.3.5 Eurofins Scientific Recent Development
7.4 GenScript Biotech
7.4.1 GenScript Biotech Company Information
7.4.2 GenScript Biotech Introduction and Business Overview
7.4.3 GenScript Biotech Gene Fragment Sales, Revenue and Gross Margin (2019-2024)
7.4.4 GenScript Biotech Gene Fragment Product Offerings
7.4.5 GenScript Biotech Recent Development
7.5 Azenta Life Sciences
7.5.1 Azenta Life Sciences Company Information
7.5.2 Azenta Life Sciences Introduction and Business Overview
7.5.3 Azenta Life Sciences Gene Fragment Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Azenta Life Sciences Gene Fragment Product Offerings
7.5.5 Azenta Life Sciences Recent Development
7.6 Twist Bioscience
7.6.1 Twist Bioscience Company Information
7.6.2 Twist Bioscience Introduction and Business Overview
7.6.3 Twist Bioscience Gene Fragment Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Twist Bioscience Gene Fragment Product Offerings
7.6.5 Twist Bioscience Recent Development
7.7 Synbio Technologies
7.7.1 Synbio Technologies Company Information
7.7.2 Synbio Technologies Introduction and Business Overview
7.7.3 Synbio Technologies Gene Fragment Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Synbio Technologies Gene Fragment Product Offerings
7.7.5 Synbio Technologies Recent Development
7.8 Bio Basic
7.8.1 Bio Basic Company Information
7.8.2 Bio Basic Introduction and Business Overview
7.8.3 Bio Basic Gene Fragment Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Bio Basic Gene Fragment Product Offerings
7.8.5 Bio Basic Recent Development
7.9 BiOligo Biotechnology
7.9.1 BiOligo Biotechnology Company Information
7.9.2 BiOligo Biotechnology Introduction and Business Overview
7.9.3 BiOligo Biotechnology Gene Fragment Sales, Revenue and Gross Margin (2019-2024)
7.9.4 BiOligo Biotechnology Gene Fragment Product Offerings
7.9.5 BiOligo Biotechnology Recent Development
8 Industry Chain Analysis
8.1 Gene Fragment Industrial Chain
8.2 Gene Fragment Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Gene Fragment Sales Model
8.5.2 Sales Channel
8.5.3 Gene Fragment Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
Integrated DNA Technologies
Thermo Scientific
Eurofins Scientific
GenScript Biotech
Azenta Life Sciences
Twist Bioscience
Synbio Technologies
Bio Basic
BiOligo Biotechnology
听
听
*If Applicable.
